Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma

Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma

Over the past two decades, the improvement in our understanding of the biology of MM and the introduction of new drug classes, including immunomodulatory drugs (IMiDs), proteasome inhibitors (PI), and monoclonal antibodies (MoAb), have significantly improved outcomes. The first IMiD introduced to tr...

Full description

Bibliographic Details
Main Authors: Grzegorz Charliński, David H. Vesole, Artur Jurczyszyn
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
cereblon E3 ligase modulators
immunomodulatory drugs
multiple myeloma
therapy
Online Access:https://www.mdpi.com/2072-6694/13/18/4666

Similar Items

Similar Items